Cytopenias in Hospitalized Patients of Corona Virus Infection(COVID-19) During First and Other Waves
1 other identifier
observational
202
1 country
1
Brief Summary
Demographic, Clinical and laboratory data as well as outcome of total 202 COVID-19 patients who were Polymerase Chain Reaction (PCR) positive and admitted in Fatima memorial Hospital, Lahore, Pakistan, was collected during first and other waves. Data of First wave is from May 2020 to July 2020, second wave from early November to Mid December 2020 and third wave from Mid march to June 2021. Investigator analyzed the data on basis of Systemic immune inflammatory index (SII) as well hematological parameters of First Wave were compared to other waves of COVID-19.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedFirst Submitted
Initial submission to the registry
February 8, 2022
CompletedFirst Posted
Study publicly available on registry
February 28, 2022
CompletedFebruary 28, 2022
February 1, 2022
1.2 years
February 8, 2022
February 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Cytopenias in Hospitalized Patients of COVID-19 During First and Other waves
extent of cytopenias is being measured in COVID-19 hospitalized patients.
4 weeks
Eligibility Criteria
COVID-19 Positive Hospitalized patients, of all genders and all age group.
You may qualify if:
- COVID-19 Positive Hospitalized patients
- All genders
You may not qualify if:
- Patients with Known hematological disorders
- Patients with known chronic Liver Disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fatima memorial Hospital
Lahore, Punjab Province, 54000, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
February 8, 2022
First Posted
February 28, 2022
Study Start
May 1, 2020
Primary Completion
June 30, 2021
Study Completion
June 30, 2021
Last Updated
February 28, 2022
Record last verified: 2022-02